Panel to Weigh Reinstating Drug for Multiple Sclerosis (New York Times)
WASHINGTON, March 6 (AP) An advisory panel of the Food and Drug Administration will begin discussing Tuesday whether to permit a promising multiple sclerosis drug to return to the market, according to documents released Monday.